Register Login

QUINCE THERAPEUTICS, INC. (QNCX)

SymbolQNCX
NameQUINCE THERAPEUTICS, INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
Address611 GATEWAY BLVD,SUITE 273, SOUTH SAN FRANCISCO, California, 94080, United States
Telephone+1 415 910-5717
Fax—
Email—
Websitehttps://www.quincetx.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001662774
Description

Quince Therapeutics, Inc., is a late-stage biotechnology company dedicated to unlocking the power of a patients own biology for the treatment of rare diseases. The companys Phase 3 lead asset, EryDex, is the first product in development that leverages its proprietary Autologous Intracellular Drug Encapsulation, or AIDE, technology platform, which is a novel drug/device combination that uses an automated process designed to encapsulate a drug into the patients own red blood cells.

Additional info from NASDAQ:
Quince Therapeutics, Inc., is a late-stage biotechnology company dedicated to unlocking the power of a patients own biology for the treatment of rare diseases. The companys Phase 3 lead asset, EryDex, is the first product in development that leverages its proprietary Autologous Intracellular Drug Encapsulation, or AIDE, technology platform, which is a novel drug/device combination that uses an automated process designed to encapsulate a drug into the patients own red blood cells.

2026-08-17 10:01

(99% Neutral) QUINCE THERAPEUTICS, INC. (QNCX) Files Form 8-K

Read more
2026-08-14 22:21

New Form SCHEDULE 13G - Quince Therapeutics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001193125-26-352966 <b>Size:</b> 154 KB

Read more
2026-08-14 17:45

New Form SCHEDULE 13G/A - Quince Therapeutics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001104659-26-097291 <b>Size:</b> 10 KB

Read more
2026-08-14 15:05

New Form SCHEDULE 13G - Quince Therapeutics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003692 <b>Size:</b> 12 KB

Read more
2026-08-14 12:21

(30% Negative) QUINCE THERAPEUTICS, INC. (QNCX) Reports Q3 2026 Financial Results

Read more
2026-08-14 12:00

Quince Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Update

Read more
2026-08-14 07:09

New Form SCHEDULE 13G - Quince Therapeutics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003433 <b>Size:</b> 16 KB

Read more
2026-07-31 20:50

(99% Neutral) QUINCE THERAPEUTICS, INC. (QNCX) Announces New Board Appointment

Read more
2026-07-31 17:48

New Form PRE 14A - Quince Therapeutics, Inc. <b>Filed:</b> 2026-07-31 <b>AccNo:</b> 0001193125-26-328777 <b>Size:</b> 4 MB

Read more
2026-07-31 17:46

New Form S-3 - Quince Therapeutics, Inc. <b>Filed:</b> 2026-07-31 <b>AccNo:</b> 0001193125-26-328769 <b>Size:</b> 719 KB

Read more